Compare HLI & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HLI | COO |
|---|---|---|
| Founded | 1972 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 15.5B |
| IPO Year | 2015 | N/A |
| Metric | HLI | COO |
|---|---|---|
| Price | $179.65 | $81.98 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $205.38 | $85.82 |
| AVG Volume (30 Days) | 367.8K | ★ 3.3M |
| Earning Date | 10-30-2025 | 12-04-2025 |
| Dividend Yield | ★ 1.34% | N/A |
| EPS Growth | ★ 26.59 | N/A |
| EPS | ★ 6.19 | 1.87 |
| Revenue | $2,565,361,000.00 | ★ $4,092,400,000.00 |
| Revenue This Year | $15.23 | $6.66 |
| Revenue Next Year | $13.29 | $5.54 |
| P/E Ratio | ★ $29.04 | $43.53 |
| Revenue Growth | ★ 21.00 | 5.06 |
| 52 Week Low | $137.99 | $61.78 |
| 52 Week High | $211.78 | $104.47 |
| Indicator | HLI | COO |
|---|---|---|
| Relative Strength Index (RSI) | 49.37 | 72.89 |
| Support Level | $171.77 | $75.25 |
| Resistance Level | $178.75 | $78.69 |
| Average True Range (ATR) | 3.98 | 2.48 |
| MACD | 1.22 | 0.47 |
| Stochastic Oscillator | 81.63 | 55.39 |
Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.